aurintricarboxylic acid has been researched along with aphidicolin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breder, J; Rüller, E; Rüller, S; Schlaak, M; van der Bosch, J | 1 |
| Geller, HM; Morris, EJ | 1 |
2 other study(ies) available for aurintricarboxylic acid and aphidicolin
| Article | Year |
|---|---|
Induction of cell death by cytokines in cell cycle-synchronous tumor cell populations restricted to G1 and G2.
Topics: Aphidicolin; Aurintricarboxylic Acid; Cell Cycle; Cell Death; Cells, Cultured; Cytokines; DNA; Endonucleases; Flow Cytometry; G1 Phase; G2 Phase; Humans; Mercaptoethylamines; Mimosine; Monocytes; Tumor Cells, Cultured | 1996 |
Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aphidicolin; Apoptosis; Astrocytes; Aurintricarboxylic Acid; Camptothecin; Cell Cycle; Cell Survival; Cells, Cultured; Cerebral Cortex; DNA; DNA Topoisomerases, Type I; Enzyme Inhibitors; Models, Neurological; Neurons; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA; Stereoisomerism; Topoisomerase I Inhibitors | 1996 |